Yuta Ohira

Inhibition of P-type ATPases by [(dihydroindenyl)oxy]acetic acid (DIOA), a K+–Cl− cotransporter inhibitor

Takuto Fujii, Yuta Ohira, Yasuo Itomi et al. · European Journal of Pharmacology · 2007 · 18 citations

Life Sciences, Biochemistry, Pharmacology +8

Z-505 hydrochloride ameliorates chemotherapy-induced anorexia in rodents via activation of the ghrelin receptor, GHSR1a

Yoshihiro Shiomi, Yuta Ohira, Makoto Yoshimura et al. · European Journal of Pharmacology · 2017 · 18 citations

Medicine, Endocrinology, Pharmacology +12

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice

Makoto Yoshimura, Yoshihiro Shiomi, Yuta Ohira et al. · European Journal of Pharmacology · 2017 · 17 citations

Medicine, Oncology, Pharmacology +14

Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics

Yoichiro Ogama, Yuji Kumagai, Norio Komatsu et al. · Clinical Pharmacology in Drug Development · 2022 · 14 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Z-100, extracted from Mycobacterium tuberculosis strain Aoyama B, promotes TNF-α production via nucleotide-binding oligomerization domain containing 2 (Nod2)-dependent NF-κB activation in RAW264.7 cells

Kokichi Katsunuma, Koji Yoshinaga, Yuta Ohira et al. · Molecular Immunology · 2014 · 10 citations

Life Sciences, Immunology, Molecular Biology +16